Literature DB >> 2020353

Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension.

T Hannedouche1, M Godin, D Fries, J P Fillastre.   

Abstract

Acute reversible renal failure is a widely recognized potential complication of angiotensin-converting enzyme inhibitor (ACEI) administration in renovascular hypertension, particularly in bilateral artery stenosis or stenosis involving a solitary kidney. We report herein 2 cases of a rare but severe complication, i.e., acute renal artery thrombosis. Whereas marked hypotension does not seem to be necessary to trigger acute renal failure following ACE inhibition, by contrast, the fall in blood pressure could play an important role in our patients. Since single-dose ACEI has been advocated in order to improve the predictive value of renal scintigraphy or plasma renin activity measurements in the diagnosis of renovascular hypertension, the potential risk of this approach should be stressed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020353     DOI: 10.1159/000186257

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Renal Artery Occlusion Due to Angiotensin-Converting Enzyme Inhibition and Reintervention for in-Stent Stenosis.

Authors:  Brian Funaki
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

2.  Renal artery stenosis: a classic presentation, a rare cause...

Authors:  Karen J Woittiez; Marjolijn van Buren; Jozef Kesecioglu
Journal:  BMJ Case Rep       Date:  2012-08-13

Review 3.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 4.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.